Associations between increased renal resistive index and cardiovascular events

Kaoru Komuro1, Noriko Yokoyama2, Misaki Shibuya2

  • 1Department of Cardiology, National Hospital Organization Hakodate Hospital, 18-16 Kawahara, Hakodate, Hokkaido, 041-8512, Japan. kkaoru@hnh.hosp.go.jp.

Insights

Renal resistive index (RI) is a valuable marker for predicting cardiovascular events in patients with cardiovascular disease (CVD). Higher RI indicates impaired kidney function and increased cardiac risk.

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Imaging

Background:

  • Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD).
  • Renal resistive index (RI), measured by Doppler ultrasonography, is linked to renal impairment.
  • The relationship between RI, cardiac function, and cardiac events in CVD patients requires further investigation.

Purpose of the Study:

  • To investigate the association between renal resistive index (RI) and cardiac function in patients with CVD.
  • To evaluate the predictive utility of RI for cardiac events in this population.

Main Methods:

  • 452 patients with CVD underwent renal Doppler ultrasonography and echocardiography.
  • Correlations between RI, serum creatinine, and estimated glomerular filtration rate (eGFR) were analyzed.
  • RI was compared between patients who experienced cardiovascular events and matched controls.

Main Results:

  • RI showed significant but moderate correlations with serum creatinine and eGFR.
  • RI was positively correlated with age, left atrial volume index, left ventricular mass index, and the E/e' ratio.
  • RI was significantly higher in patients hospitalized with cardiovascular events compared to controls, despite similar age and eGFR.

Conclusions:

  • Renal RI reflects intrarenal hemodynamic impairment not fully captured by eGFR alone.
  • Assessing renal RI can augment prognostic estimates for patients with CVD.
Abstract

Related Concept Videos

Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
12.7K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733